"Maytansine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ansa macrolide isolated from the MAYTENUS genus of East African shrubs.
Descriptor ID |
D008453
|
MeSH Number(s) |
D02.540.505.495 D04.345.295.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Maytansine".
Below are MeSH descriptors whose meaning is more specific than "Maytansine".
This graph shows the total number of publications written about "Maytansine" by people in this website by year, and whether "Maytansine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 2 | 0 | 2 |
2018 | 2 | 1 | 3 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Maytansine" by people in Profiles.
-
Ocular Toxicity of Mirvetuximab. Cornea. 2019 Feb; 38(2):229-232.
-
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer. Breast. 2018 Oct; 41:137-143.
-
Never too old to fight breast cancer: A case report. Medicine (Baltimore). 2018 Mar; 97(9):e9981.
-
Emilia: use cunning to survive cancer. Chin Clin Oncol. 2018 02; 7(1):5.
-
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? Future Oncol. 2017 Dec; 13(30):2791-2797.
-
NICE approves trastuzumab emtansine after deal with drug company. BMJ. 2017 06 15; 357:j2930.